-The Times of India NEW DELHI: In a move that could significantly bring down prices of expensive medicines, a high-level committee has recommended capping of trade margins for costly drugs at 35% of MRP (maximum retail price). The recommendations - part of a report submitted by an inter-ministerial committee - have been put in the public domain by the Department of Pharmaceuticals, inviting comments on the suggestions. The committee was set up...
More »SEARCH RESULT
Those under watch ineligible for income declaration scheme -Vikas Dhoot
-The Hindu The scheme also shuts out ‘innocent’ taxpayers who filed returns on time but whose cases were chosen for scrutiny to verify claims. Tax payers, whose returns were picked for random scrutiny by the authorities in recent years, would not be eligible to turn concealed income into ‘white’ under the Income Declaration Scheme (IDS), announced in the Union Budget to bring black money into the tax net. Experts believe this may...
More »Policy shame: sick, rare and ignored -Shilpi Bhattacharya
-The Hindu If the Indian government is serious about its commitment to realise the rights of its citizens to universal and equitable health care, it cannot ignore rare diseases. The draft National Health Policy, 2015, makes no mention of them Rare diseases are a diverse set of over 7,000 different conditions that afflict an estimated 1 in 20 Indians and 350 million people worldwide. Put simply, it means that every bus on...
More »Drug pricing: a bitter pill to swallow -Feroze Varun Gandhi
-The Hindu Medicines remain overpriced and unaffordable in India. In a country mired in poverty, medical debt remains the second biggest factor for keeping millions in poverty. The international pharmaceutical industry has found its cash cow in India’s beleaguered consumers. With a minimum wage of Rs.250/day for a government worker, a basic wage worker afflicted with a chronic disease like multi-drug-resistant tuberculosis faces penury. His treatment, with drug combinations, which works out...
More »Spluttering against TB -Chapal Mehra
-The Hindu India has close to 1,00,000 cases of drug-resistant TB, most of which remain undiagnosed and untreated. So India’s state of preparedness to fight DR TB remains questionable. In a small, airless room in Dharavi, Owais sat chatting with his wife and two children. Outside, the famous rains of Mumbai beat down relentlessly on the thousands of tiny rooms that dot Dharavi. “I hope it doesn’t flood,” said Owais’s wife as he...
More »